Latest Articles

Event rates and Risk Factors for Recurrent CV Events

Public health recommendations for Lp(a) measurement

ESC Lp(a) in Clinical practice EAS Consensus statement

CV Risk management in T1DM using guidelines

APSC Consensus Recommendations on Dyslipidemia

VTE incidence after cesarean delivery

Venous thromboembolism incidence in patients recommended for pharmacologic prophylaxis after cesarean delivery based on different risk stratification guidelines.

Unmet clinical needs in the management of VTE in at-risk patients

Statin/Ezetimibe Combination VS Statin Monotherapy

The European experience: Swedeheart and AIFA registries

Highlights on the most recent real-world data on the use of PCSK9 inhibitors, including those from the Swedeheart and AIFA registries.